Lutrate 1 month Depot 3.75 mg powder and solvent for prolonged-release suspension for injection İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

lutrate 1 month depot 3.75 mg powder and solvent for prolonged-release suspension for injection

mercury pharmaceuticals ltd - leuprorelin acetate - powder and solvent for suspension for injection - 3.75 milligram(s) - gonadotropin releasing hormone analogues; leuprorelin - endocrine therapy. hormones and related agents. gonadotropin-releasing hormones analogues - it is indicated for palliative treatment of locally advanced or metastatic prostate cancer

Lutrate 3 month Depot 22.5 mg powder and solvent for prolonged-release suspension for injection İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

lutrate 3 month depot 22.5 mg powder and solvent for prolonged-release suspension for injection

mercury pharmaceuticals ltd - leuprorelin acetate - powder and solvent for suspension for injection - 22.5 milligram(s) - gonadotropin releasing hormone analogues; leuprorelin - endocrine therapy. hormones and related agents. gonadotropin-releasing hormones analogues - it t is indicated for palliative treatment of hormone dependent advanced prostate cancer

LERIN leuprorelin (as acetate) 5 mg implant pre-filled syringe Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

lerin leuprorelin (as acetate) 5 mg implant pre-filled syringe

sandoz pty ltd - leuprorelin acetate, quantity: 5.25 mg (equivalent: leuprorelin, qty 5 mg) - implant - excipient ingredients: polylactic acid - palliative treatment of patients with advanced prostate carcinoma.

LERIN leuprorelin (as acetate) 3.6 mg implant pre-filled syringe Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

lerin leuprorelin (as acetate) 3.6 mg implant pre-filled syringe

sandoz pty ltd - leuprorelin acetate, quantity: 3.78 mg (equivalent: leuprorelin, qty 3.67 mg) - implant - excipient ingredients: polyglactin - palliative treatment of patients with advanced prostate carcinoma.

ELIGARD 7.5mg powder and solvent for solution for injection Malta - İngilizce - Medicines Authority

eligard 7.5mg powder and solvent for solution for injection

astellas pharma europe b.v. sylviusweg 62, 2333 be, leiden, netherlands - leuprorelin acetate - powder and solvent for solution for injection - leuprorelin acetate 7.5 mg - endocrine therapy

ELIGARD 22.5mg powder and solvent for solution for injection Malta - İngilizce - Medicines Authority

eligard 22.5mg powder and solvent for solution for injection

astellas pharma europe b.v. sylviusweg 62, 2333 be, leiden, netherlands - leuprorelin acetate - powder and solvent for solution for injection - leuprorelin acetate 22.5 mg - endocrine therapy

ELIGARD 45mg powder and solvent for solution for injection Malta - İngilizce - Medicines Authority

eligard 45mg powder and solvent for solution for injection

astellas pharma europe b.v. sylviusweg 62, 2333 be, leiden, netherlands - leuprorelin acetate - powder and solvent for solution for injection - leuprorelin acetate 45 mg - endocrine therapy

Prostap SR DCS 3.75mg Powder and Solvent for Prolonged-release Suspension for Injection Malta - İngilizce - Medicines Authority

prostap sr dcs 3.75mg powder and solvent for prolonged-release suspension for injection

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - leuprorelin acetate - powder and solvent for suspension for injection - leuprorelin acetate 3.75 mg - endocrine therapy

Lutrate 1 month Depot 3.75mg Powder & Solvent for prolonged-release Suspension for Injection Malta - İngilizce - Medicines Authority

lutrate 1 month depot 3.75mg powder & solvent for prolonged-release suspension for injection

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - leuprorelin acetate - powder and solvent for prolonged-release suspension for injection - leuprorelin acetate 3.75 mg - endocrine therapy

Prostap SR DCS 3.75mg Pdr & solv for prolonged-release susp for injection in pre-filled syringee Malta - İngilizce - Medicines Authority

prostap sr dcs 3.75mg pdr & solv for prolonged-release susp for injection in pre-filled syringee

health house pharma ltd t/as p&d pharmaceuticals ltd 38 woolmer way, bordon, hampshire, gu35 9q, united kingdom - leuprorelin acetate - powder and suspension for suspension for injection - leuprorelin acetate 3.75 mg - endocrine therapy